Chronic superantigen exposure induces systemic inflammation, elevated bloodstream endotoxin, and abnormal glucose tolerance in rabbits: Possible role in diabetes

mBio

Volumn 6, Issue 2, 2015, Pages

  Vu, Bao G ^a   Stach, Christopher S ^a   Kulhankova, Katarina ^a   Salgado Pabón, Wilmara ^a   Klingelhutz, Aloysius J ^a   Schlievert, Patrick M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; SUPERANTIGEN; TOXIC SHOCK SYNDROME TOXIN 1; TUMOR NECROSIS FACTOR ALPHA; BACTERIAL TOXIN; ENDOTOXIN; ENTEROTOXIN; ENTEROTOXIN F, STAPHYLOCOCCAL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; HUMAN; HUMAN CELL; IMPAIRED GLUCOSE TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INSULIN RESISTANCE; LIPOLYSIS; LIVER INJURY; LONG TERM EXPOSURE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RABBIT; UPREGULATION; ANIMAL; BLOOD; COMPLICATION; DIABETES MELLITUS, TYPE 2; GLUCOSE TOLERANCE TEST; PATHOLOGY; PATHOPHYSIOLOGY; SECRETION (PROCESS); STAPHYLOCOCCUS INFECTION;

ORYCTOLAGUS CUNICULUS; STAPHYLOCOCCUS AUREUS;

ANIMALS; BACTERIAL TOXINS; DIABETES MELLITUS, TYPE 2; ENDOTOXINS; ENTEROTOXINS; GLUCOSE TOLERANCE TEST; INFLAMMATION; RABBITS; STAPHYLOCOCCAL INFECTIONS; SUPERANTIGENS;

EID: 84929501223     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.02554-14     Document Type: Article

References (42)

1. International Diabetes Federation. 2013. Global burden of diabetes. Diabetic atlas, 6th ed. Brussels, Belgium. Accessed 17 October 2014. http://www.idf.org/diabetesatlas.
2. Zimmet P, Alberti KG, Shaw J. 2001. Global and societal implications of the diabetes epidemic. Nature 414:782–787. http://dx.doi.org/10.1038/414782a.
3. Nathan DM. 1993. Long-term complications of diabetes mellitus. N Engl J Med 328: 1676-1685. http://dx.doi.org/10.1056/NEJM199306103282306.
4. Olokoba AB, Obateru OA, Olokoba LB. 2012. Type 2 diabetes mellitus: a review of current trends. Oman Med J 27:269–273. http://dx.doi.org/10.5001/omj.2012.68.
5. Creely SJ, McTernan PG, Kusminski CM, Fisher FM, Da Silva NF, Khanolkar M, Evans M, Harte AL, Kumar S. 2007. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 292: E740–E747. http://dx.doi.org/10.1152/ajpendo.00302.2006.
6. Venables MC, Jeukendrup AE. 2009. Physical inactivity and obesity: links with insulin resistance and type 2 diabetes mellitus. Diabetes Metab Res Rev 25(Suppl 1):S18-S23. http://dx.doi.org/10.1002/dmrr.983.
7. Piya MK, McTernan PG, Kumar S. 2013. Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin. J Endocrinol 216:T1–T15. http://dx.doi.org/10.1530/JOE-12-0498.
8. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. 2006. Microbial ecology: human gut microbes associated with obesity. Nature 444:1022–1023. http://dx.doi.org/10.1038/4441022a.
9. Walters WA, Xu Z, Knight R. 2014. Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Lett 588:4223–4233. http://dx.doi.org/10.1016/j.febslet.2014.09.039.
10. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, Gordon JI, Relman DA, Fraser-Liggett CM, Nelson KE. 2006. Metagenomic analysis of the human distal gut microbiome. Science 312: 1355–1359. http://dx.doi.org/10.1126/science.1124234.
11. Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI. 2004. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 101: 15718–15723. http://dx.doi.org/10.1073/pnas.0407076101.
12. Olsen K, Danielsen K, Wilsgaard T, Sangvik M, Sollid JU, Thune I, Eggen AE, Simonsen GS, Furberg AS. 2013. Obesity and Staphylococcus aureus nasal colonization among women and men in a general population. PLoS One 8:e63716. http://dx.doi.org/10.1371/journal.pone.0063716.
13. Early GJ, Seifried SE. 2012. Risk factors for community-associated Staphylococcus aureus skin infection in children of Maui. Hawaii J Med Public Health 71:218–223.
14. Spaulding AR, Salgado-Pabón W, Kohler PL, Horswill AR, Leung DY, Schlievert PM. 2013. Staphylococcal and streptococcal superantigen exotoxins. Clin Microbiol Rev 26:422-447. http://dx.doi.org/10.1128/CMR.00104-12.
15. Spaulding AR, Salgado-Pabón W, Merriman JA, Stach CS, Ji Y, Gillman AN, Peterson ML, Schlievert PM. 2014. Vaccination against Staphylococcus aureus pneumonia. J Infect Dis 209:1955–1962. http://dx.doi.org/10.1093/infdis/jit823.
16. Spaulding AR, Lin YC, Merriman JA, Brosnahan AJ, Peterson ML, Schlievert PM. 2012. Immunity to Staphylococcus aureus secreted proteins protects rabbits from serious illnesses. Vaccine 30:5099-5109. http://dx.doi.org/10.1016/j.vaccine.2012.05.067.
17. Strandberg KL, Rotschafer JH, Vetter SM, Buonpane RA, Kranz DM, Schlievert PM. 2010. Staphylococcal superantigens cause lethal pulmonary disease in rabbits. J Infect Dis 202:1690-1697. http://dx.doi.org/10.1086/657156.
18. Crispe IN. 2003. Hepatic T cells and liver tolerance. Nat Rev Immunol 3:51–62. http://dx.doi.org/10.1038/nri981.
19. Björnholm M, Zierath JR. 2005. Insulin signal transduction in human skeletal muscle: identifying the defects in type II diabetes. Biochem Soc Trans 33:354–357. http://dx.doi.org/10.1042/BST0330354.
20. Samuel VT, Shulman GI. 2012. Mechanisms for insulin resistance: common threads and missing links. Cell 148:852-871. http://dx.doi.org/10.1016/j.cell.2012.02.017.
21. Zechner R, Zimmermann R, Eichmann TO, Kohlwein SD, Haemmerle G, Lass A, Madeo F. 2012. Fat signals-lipases and lipolysis in lipid metabolism and signaling. Cell Metab 15:279-291. http://dx.doi.org/10.1016/j.cmet.2011.12.018.
22. Schlievert PM, Nemeth KA, Davis CC, Peterson ML, Jones BE. 2010. Staphylococcus aureus exotoxins are present in vivo in tampons. Clin Vaccine Immunol 17:722–727. http://dx.doi.org/10.1128/CVI.00483-09.
23. Rosten PM, Bartlett KH, Chow AW. 1987. Detection and quantitation of toxic shock syndrome toxin 1 in vitro and in vivo by noncompetitive enzyme-linked immunosorbent assay. J Clin Microbiol 25:327–332.
24. Salgado-Pabón W, Schlievert PM. 2014. Models matter: the search for an effective Staphylococcus aureus vaccine. Nat Rev Microbiol 12:585–591. http://dx.doi.org/10.1038/nrmicro3308.
25. Lin Y, Sun Z. 2010. Current views on type 2 diabetes. J Endocrinol 204: 1–11. http://dx.doi.org/10.1677/JOE-09-0260.
26. Vu BG, Stach CS, Salgado-Pabón W, Diekema DJ, Gardner SE, Schlievert PM. 2014. Superantigens of Staphylococcus aureus from patients with diabetic foot ulcers. J Infect Dis 210:1920-1927. http://dx.doi.org/10.1093/infdis/jiu350.
27. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, Finnerty CC, López CM, Honari S, Moore EE, Minei JP, Cuschieri J, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Jeschke MG, Klein MB, Gamelli RL, Gibran NS, Brownstein BH, Miller-Graziano C, Calvano SE, Mason PH, Cobb JP, Rahme LG, Lowry SF, Maier RV, Moldawer LL, Herndon DN, Davis RW, Xiao W, Tompkins RG, Inflammation and Host Response to Injury, Large Scale Collaborative Research Program. 2013. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 110: 3507–3512. http://dx.doi.org/10.1073/pnas.1222878110.
28. Parsonnet J, Hansmann MA, Delaney ML, Modern, Parsonnet J, Hansmann MA, Delaney ML, Modern PA, Dubois AM, Wieland-Alter W, Wissemann KW, Wild JE, Jones MB, Seymour JL, Onderdonk AB. 2005. Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women. J Clin Microbiol 43:4628-4634. http://dx.doi.org/10.1128/JCM.43.9.4628-4634.2005.
29. Schlievert PM. 1982. Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C. Infect Immun 36:123–128.
30. Fujiwaka H, Igarashi H, Usami H, Tanaka S, Tamura H. 1986. Clearance of endotoxin from blood of rabbits injected with staphylococcal toxic shock syndrome toxin-1. Infect Immun 52:134–137.
31. Levinthal GN, Tavil AS. 1999. Liver disease and diabetes mellitus. Clin Diabetes http://journal.diabetes.org/clinicaldiabetes/v17n21999/Pg73.htm.
32. Banke E, Rödström K, Ekelund M, Dalla-Riva J, Lagerstedt JO, Nilsson S, Degerman E, Lindkvist-Petersson K, Nilson B. 2014. Superantigen activates the gp130 receptor on adipocytes resulting in altered adipocyte metabolism. Metab Clin Exp 63:831-840. http://dx.doi.org/10.1016/j.metabol.2014.03.004.
33. Gargano LM, Hughes JM. 2014. Microbial origins of chronic diseases. Annu Rev Public Health 35:65-82. http://dx.doi.org/10.1146/annurev-publhealth-032013-182426.
34. Vu BG, Gourronc FA, Bernlohr DA, Schlievert PM, Klingelhutz AJ. 2013. Staphylococcal superantigens stimulate immortalized human adipocytes to produce chemokines. PLoS One 8:e77988. http://dx.doi.org/10.1371/journal.pone.0077988.
35. McTernan PG, Anderson LA, Anwar AJ, Eggo MC, Crocker J, Barnett AH, Stewart PM, Kumar S. 2002. Glucocorticoid regulation of p450 aromatase activity in human adipose tissue: gender and site differences. J Clin Endocrinol Metab 87:1327–1336. http://dx.doi.org/10.1210/jcem.87.3.8288.
36. Parsonnet J, Gillis ZA, Richter AG, Pier GB. 1987. A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1. Infect Immun 55:1070–1076.
37. Blomster-Hautamaa DA, Schlievert PM. 1988. Preparation of toxic shock syndrome toxin-1. Methods Enzymol 165:37–43.
38. Westphal O, Luderitz O, Keiderling W. 1952. Effects of bacterial toxins; biochemical analysis of inflammation. Zentralbl Bakteriol Parasitenkd Infektionskr Hyg 158:152–160.
39. Blake MS, Johnston KH, Russell-Jones GJ, Gotschlich EC. 1984. A rapid, sensitive method for detection of alkaline phosphatase-conjugated antiantibody on Western blots. Anal Biochem 136:175–179. http://dx.doi.org/10.1016/0003-2697(84)90320-8.
40. Yamamoto N, Ueda M, Sato T, Kawasaki K, Sawada K, Kawabata K, Ashida H. 2011. Measurement of glucose uptake in cultured cells. Curr Protoc Pharmacol 12:14.1–14.22. http://dx.doi.org/10.1002/0471141755.ph1214s55.
41. Roggiani M, Stoehr JA, Olmsted SB, Matsuka YV, Pillai S, Ohlendorf DH, Schlievert PM. 2000. Toxoids of streptococcal pyrogenic exotoxin A are protective in rabbit models of streptococcal toxic shock syndrome. Infect Immun 68:5011–5017. http://dx.doi.org/10.1128/IAI.68.9.5011-5017.2000.
42. World Health Organization. 2008. Overweight/obesity, 2008. Prevalence of obesity, ages 20_, age standardized: both sexes. http://gamapserver.who.int/gho/interactive_charts/ncd/risk_factors/overweight_obesity/atlas.html?indicator_i1&date_bothsexes